Hospital AI startup Healthleap closes $38M, $23.8M annualized impact at Penn Medicine

Healthleap, a startup that uses AI to read patient charts and flag hospital patients who may have undiagnosed conditions, recently closed a combined $38 million in seed and Series A funding. The funding was exclusively reported by TechCrunch, comprising an $8 million seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The company did not disclose its valuation. The report was published by TechCrunch's Ram Iyer on October 7, 2026.

Healthleap was co-founded in 2022 in South Africa by siblings Jemima Meyer and Josiah Meyer, with the initial product being a clinical nutrition tool Jemima built for dietitians. The company later pivoted strategically to build a more general-purpose platform aimed at identifying hospitalized patients who may have conditions like malnutrition or delirium but have not been caught early. Per CEO and co-founder Josiah Meyer, the company's core method is to extract affirmative or negative mentions of clinical information from patient charts and process them in a scalable, structured way.

On the technical side, Healthleap's platform is already deployed in over 50 hospitals, screening patients for malnutrition and delirium. The company has also developed identification programs for aspiration pneumonia, pressure ulcers, and congestive heart failure readmission risk, currently in ongoing clinical validation. Operationally, Healthleap plugs into hospital EHR systems and uses language models to extract information from clinician notes, such as records of weight loss or difficulty swallowing. These analyses are then combined with structured data like lab reports and vital signs to flag patients needing further attention. The company explicitly emphasizes that its software does not diagnose patients, but only flags items needing additional evaluation. Josiah further explains: "We analyze every adult inpatient's chart every night, including lab results, vitals, weight, medications, dietary orders, diagnoses, and clinician notes. The next morning, we write a risk score into the existing workflow of the care team, and provide more information about patient trends through an accessible dashboard."

Malnutrition is a strong practical starting point for Healthleap, because it is often undiagnosed and negatively impacts patient recovery in many ways. Research shows that 20% to 50% of hospitalized patients have malnutrition, with some studies linking it to longer stays, impaired wound healing, other complications, and higher morbidity and mortality. Over the past year, Healthleap's hospital partners grew from 3 to over 50, with customers now including Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare. Per Josiah, revenue grew over 10x during the same period, though specific numbers were not disclosed. On business model, Healthleap sells three-year contracts priced by hospital licensed bed count, with an outcome-based pricing model. Josiah notes: "We use the hard ROI verified and attributed to us by the hospital finance team as measurable ROI. Based on this, our contracts commit to delivering several times the contract value. To date, every customer has achieved hard ROI of 5x or more, with some cases over 20x annual total ROI."

At the Hospital of the University of Pennsylvania, Healthleap's malnutrition program delivered $23.8M annualized financial impact, of which $6.3M came from additional reimbursement and $17.5M from reduced length of stay. For the new funding, Healthleap plans to invest in engineering, product, sales, and customer success to support more condition identification development. Josiah says the company ultimately aims to cover over 40 major health conditions and expand into outpatient and home care.